Wikidata

(Q40382306)

English

Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model

scientific article published on August 2005

In more languages

Statements

title
Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017
author name string
Francisco J Hernandez-Ilizaliturri
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017
Nishitha Reddy
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017
Beata Holkova
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017
Edris Ottman
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017
Myron S Czuczman
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017
publication date
1 August 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017
page(s)
5984-5992
1 reference
stated in
Europe PubMed Central
PubMed ID
16115943
retrieved
20 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40382306&oldid=1896495758"